EMERGENT BIOSOLUTIONS INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
EMERGENT BIOSOLUTIONS INC. (EBS) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $63.90 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-27
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $63.90M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $65.10M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $65.10M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $71.50M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $63.90M 10-K · filed 2026-02-27 |
| 2024-12-31 | $65.10M 10-K · filed 2025-03-04 |
| 2023-12-31 | $65.10M 10-K · filed 2024-03-08 |
| 2022-12-31 | $71.50M 10-K/A · filed 2023-12-11 |
| 2021-12-31 | $55.90M 10-K · filed 2022-02-25 |
| 2020-12-31 | $58.60M 10-K · filed 2021-02-19 |
| 2019-12-31 | $58.70M 10-K · filed 2020-02-25 |
| 2018-12-31 | $57.70K 10-K · filed 2019-02-22 |
| 2017-12-31 | $15.65M 10-K · filed 2018-02-23 |
| 2016-12-31 | $6.22M 10-K · filed 2017-02-28 |
| 2015-12-31 | $8.98M 10-K · filed 2016-02-29 |
| 2014-12-31 | $8.63M 10-K · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |